Myelin Oligodendrocyte Glycoprotein Antibody-Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions

Affiliations

¹ Department of Neurology, Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
² Department of Neurology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.

Sohyeon Kim et al. Ann Neurol. 2024 Feb.

. 2024 Feb;95(2):415.

doi: 10.1002/ana.26859. Epub 2023 Dec 21.

¹ Department of Neurology, Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
² Department of Neurology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.

No abstract available

References

1. Villacieros-Alvarez J, Espejo C, Arrambide G, et al. Myelin oligodendrocyte glycoprotein antibodies in adults with a first demyelinating event suggestive of multiple sclerosis. Ann Neurol 2023. https://doi.org/10.1002/ana.26793.
1. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17:162-173.
1. Banwell B, Bennett JL, Marignier R, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol 2023;22:268-282.
1. Sechi E, Cacciaguerra L, Chen JJ, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol 2022;13:885218.